Amedeo Smart

Free Medical Literature Service

 

Amedeo

Arrhythmias
  Free Subscription

Articles published in
Heart
    March 2024
  1. SOORAMPALLY V, Veeraraghavan S, Kidambi BR
    Dyspnoea, dizziness and dysrhythmia in a middle-aged patient.
    Heart. 2024;110:559-614.
    >> Share

  2. ISHIKITA A, McIntosh C, Roche SL, Barron DJ, et al
    Incremental value of machine learning for risk prediction in tetralogy of Fallot.
    Heart. 2024;110:560-568.
    >> Share

  3. VINTER N, Cordsen P, Johnsen SP, Benjamin EJ, et al
    Birth cohort effects on diagnosed atrial fibrillation incidence: nationwide cohort study from 1980 to 2018.
    Heart. 2024 Mar 12:heartjnl-2023-323737. doi: 10.1136/heartjnl-2023-323737.
    >> Share

  4. SAMUEL M, Rienstra M
    Birth cohort effect in atrial fibrillation: a matter of detection?
    Heart. 2024 Mar 12:heartjnl-2024-323950. doi: 10.1136/heartjnl-2024-323950.
    >> Share

    February 2024
  5. KAMSANI SH, Middeldorp ME
    Adherence in a fortnight: is this a true reflection of a lifetime?
    Heart. 2024 Feb 8:heartjnl-2023-323800. doi: 10.1136/heartjnl-2023-323800.
    >> Share

    January 2024
  6. VAN HATTUM JC, Daems JJN, Verwijs SM, Wismans LV, et al
    Long-term cardiac follow-up of athletes infected with SARS-CoV-2 after resumption of elite-level sports.
    Heart. 2024;110:254-262.
    >> Share

  7. LAMBIASE PD
    Determining risk of sudden death: is it all in the T wave?
    Heart. 2024;110:151-153.
    >> Share

  8. HNATKOVA K, Andrsova I, Novotny T, Vanderberk B, et al
    QRS complex and T wave planarity for the efficacy prediction of automatic implantable defibrillators.
    Heart. 2024;110:178-187.
    >> Share

  9. MAASS AH
    Inequities in access and use of automated external defibrillators.
    Heart. 2024;110:154-155.
    >> Share

  10. VAN DER VELDEN RMJ, Bonander C, Crijns HJGM, Kemp-Gudmundsdottir K, et al
    Adherence to a handheld device-based atrial fibrillation screening protocol is associated with clinical outcomes.
    Heart. 2024 Jan 5:heartjnl-2023-323522. doi: 10.1136/heartjnl-2023-323522.
    >> Share

    December 2023
  11. JOHANSSON M, Fedorowski A
    Situational vs vasovagal syncope: one but different?
    Heart. 2023;110:3-4.
    >> Share

  12. SATURI G, De Frutos F, Sguazzotti M, Gonzalez-Lopez E, et al
    Predictors and outcomes of pacemaker implantation in patients with cardiac amyloidosis.
    Heart. 2023;110:40-48.
    >> Share

    November 2023
  13. FREDERIKSEN TC, Christiansen MK, Benjamin EJ, Overvad K, et al
    Interaction of genetic risk and lifestyle on the incidence of atrial fibrillation.
    Heart. 2023 Nov 28:heartjnl-2023-323333. doi: 10.1136/heartjnl-2023-323333.
    >> Share

  14. VAZIR A, Kapelios CJ
    Sleep-disordered breathing and cardiovascular disease: who and why to test and how to intervene?
    Heart. 2023;109:1864-1870.
    >> Share

  15. LAWIN D, Stellbrink C, Stellbrink E, Buck B, et al
    Alcohol septal ablation in patients aged 75 years or older with hypertrophic obstructive cardiomyopathy.
    Heart. 2023;109:1778-1784.
    >> Share

  16. BAROUTIDOU A, Arvanitaki A, Farmakis IT, Patsiou V, et al
    Transcatheter closure of atrial septal defect in the elderly: a systematic review and meta-analysis.
    Heart. 2023;109:1741-1750.
    >> Share

  17. OTTO CM
    Heartbeat: atrial fibrillation phenotyping identifies patients at high risk of adverse events.
    Heart. 2023;109:1725-1726.
    >> Share

    October 2023
  18. OTTO CM
    Heartbeat: ultra-processed foods and atrial fibrillation risk.
    Heart. 2023;109:1651-1653.
    >> Share

  19. FERKH A, Clark A, Thomas L
    Left atrial phasic function: physiology, clinical assessment and prognostic value.
    Heart. 2023;109:1661-1669.
    >> Share

  20. CHA MJ, Lee SA, Cho MS, Nam GB, et al
    Reduction of moderate to severe tricuspid regurgitation after catheter ablation for atrial fibrillation.
    Heart. 2023 Oct 25:heartjnl-2023-323244. doi: 10.1136/heartjnl-2023-323244.
    >> Share

  21. TEIGER E, Eschalier R, Amabile N, Rioufol G, et al
    Left atrial appendage closure in very elderly patients in the French National Registry.
    Heart. 2023 Oct 9:heartjnl-2023-322871. doi: 10.1136/heartjnl-2023-322871.
    >> Share

    September 2023
  22. LOPEZ-LIZARRAGA MA, Sanchez-Amaya DJ, Godinez-Cordova LB
    Paradoxical worsening of an arrhythmia due to antiarrhythmics.
    Heart. 2023;109:1515-1576.
    >> Share

  23. AKERSTROM F, Hutter J, Charitakis E, Tabrizi F, et al
    Association between catheter ablation of atrial fibrillation and mortality or stroke.
    Heart. 2023 Sep 1:heartjnl-2023-322883. doi: 10.1136/heartjnl-2023-322883.
    >> Share

    August 2023
  24. THAKUR A, Kumar S
    Palpitations in a young man after heavy work.
    Heart. 2023;109:1356-1418.
    >> Share

  25. GRIFFIN JM
    Sex differences in cardiac sarcoidosis.
    Heart. 2023;109:1346-1347.
    >> Share

  26. ISO T, Maeda D, Matsue Y, Dotare T, et al
    Sex differences in clinical characteristics and prognosis of patients with cardiac sarcoidosis.
    Heart. 2023;109:1387-1393.
    >> Share

  27. CHATTERJEE NA, Rea TD
    Shortening time to defibrillation in shockable cardiac arrest matters: how do we do it?
    Heart. 2023;109:1344-1345.
    >> Share

  28. PONNUSAMY SS, Syed T, Vijayaraman P
    Pacing induced cardiomyopathy: recognition and management.
    Heart. 2023;109:1407-1415.
    >> Share

  29. DZESHKA MS, Shantsila A, Shantsila E, Lip GYH, et al
    Better blood pressure control in patients with atrial fibrillation: overcoming barriers to improve outcomes.
    Heart. 2023 Aug 17:heartjnl-2023-323028. doi: 10.1136/heartjnl-2023-323028.
    >> Share

    July 2023
  30. ANDRADE JG, Deyell MW, Bennett R, Macle L, et al
    Assessment and management of asymptomatic atrial fibrillation.
    Heart. 2023 Jul 28:heartjnl-2023-322428. doi: 10.1136/heartjnl-2023-322428.
    >> Share

  31. ANTIPEROVITCH P, Skanes A, Klein G, Tang A, et al
    Approach to a patient with asymptomatic pre-excitation.
    Heart. 2023;109:1254-1259.
    >> Share

  32. SAU A, Pastika L, Ng FS
    Atrial fibrillation phenotypes: the route to personalised care?
    Heart. 2023 Jul 24:heartjnl-2023-322812. doi: 10.1136/heartjnl-2023-322812.
    >> Share

  33. LAMBIASE PD, Maclean E
    Review of the National Institute for Health and Care Excellence guidelines on the management of atrial and ventricular arrhythmias.
    Heart. 2023 Jul 24:heartjnl-2022-322122. doi: 10.1136/heartjnl-2022-322122.
    >> Share

  34. HALL R, Raju H, Nalliah C
    Association of diet with atrial fibrillation: villain or sidekick.
    Heart. 2023 Jul 21:heartjnl-2023-322897. doi: 10.1136/heartjnl-2023-322897.
    >> Share

  35. TRIVEDI R, Marschner S, Shaw T, Min H, et al
    Factors influencing blood pressure control in patients with atrial fibrillation and hypertension in Australian primary care.
    Heart. 2023 Jul 20:heartjnl-2023-322602. doi: 10.1136/heartjnl-2023-322602.
    >> Share

  36. BEGGS SAS, Wright GA, Gardner RS
    Primary prevention implantable cardioverter defibrillators for patients with heart failure.
    Heart. 2023 Jul 18:heartjnl-2022-321728. doi: 10.1136/heartjnl-2022-321728.
    >> Share

  37. TU SJ, Gallagher C, Elliott AD, Bradbury KE, et al
    Associations of dietary patterns, ultra-processed food and nutrient intake with incident atrial fibrillation.
    Heart. 2023 Jul 17:heartjnl-2023-322412. doi: 10.1136/heartjnl-2023-322412.
    >> Share

  38. AFOKE J, Camacho E, Bagameri G
    Recurrent ventricular arrhythmia after aortic root replacement and mitral valve repair.
    Heart. 2023;109:1145-1192.
    >> Share

  39. KOLDENHOF T, Van Gelder IC, Crijns HJ, Rienstra M, et al
    Rate control in atrial fibrillation, calcium channel blockers versus beta-blockers.
    Heart. 2023 Jul 11:heartjnl-2023-322635. doi: 10.1136/heartjnl-2023-322635.
    >> Share

  40. AL-AIDAROUS S, Protonotarios A, Elliott PM, Lambiase PD, et al
    Management of arrhythmogenic right ventricular cardiomyopathy.
    Heart. 2023 Jul 11:heartjnl-2023-322612. doi: 10.1136/heartjnl-2023-322612.
    >> Share

    June 2023
  41. OTTO CM
    Heartbeat: prediction of atrial fibrillation risk.
    Heart. 2023;109:1045-1047.
    >> Share

  42. KHAN I, Atoot A
    Patient with altered mental status.
    Heart. 2023;109:1063-1122.
    >> Share

  43. CAI H, Chen G, Hu W, Jiang C, et al
    Anticoagulant in atrial fibrillation patients with prior intracranial haemorrhage: a meta-analysis.
    Heart. 2023 Jun 15:heartjnl-2023-322492. doi: 10.1136/heartjnl-2023-322492.
    >> Share

  44. BANCHS J, Lech T
    Cardiovascular phenotypes and incident cardiovascular events in people with previous cancer.
    Heart. 2023;109:974-976.
    >> Share

  45. BEVAN G, Nazer B
    Exercise and arrhythmogenic cardiomyopathy: all things in moderation.
    Heart. 2023;109:972-973.
    >> Share

  46. RAMOS-MAQUEDA J, Migueles JH, Molina-Jimenez M, Ruiz-Gonzalez D, et al
    Lifestyle physical activity and rapid-rate non-sustained ventricular tachycardia in arrhythmogenic cardiomyopathy.
    Heart. 2023;109:992-999.
    >> Share

  47. SAITO Y, Omae Y, Nagashima K, Miyauchi K, et al
    Phenotyping of atrial fibrillation with cluster analysis and external validation.
    Heart. 2023 Jun 1:heartjnl-2023-322447. doi: 10.1136/heartjnl-2023-322447.
    >> Share

    May 2023
  48. BHATIA RT, Malhotra A, MacLachlan H, Gati S, et al
    Prevalence and diagnostic significance of de-novo 12-lead ECG changes after COVID-19 infection in elite soccer players.
    Heart. 2023;109:936-943.
    >> Share

    April 2023
  49. HATIPOGLU S, Gardezi SKM, Azzu A, Baksi J, et al
    Diagnosis of cardiac sarcoidosis in patients presenting with cardiac arrest or life-threatening arrhythmias.
    Heart. 2023;109:748-755.
    >> Share

  50. CHOI YJ, Kim HK, Hwang IC, Park CS, et al
    Prognosis of patients with hypertrophic cardiomyopathy and low-normal left ventricular ejection fraction.
    Heart. 2023;109:771-778.
    >> Share

  51. RAISI-ESTABRAGH Z, Cooper J, McCracken C, Crosbie EJ, et al
    Incident cardiovascular events and imaging phenotypes in UK Biobank participants with past cancer.
    Heart. 2023 Apr 18:heartjnl-2022-321888. doi: 10.1136/heartjnl-2022-321888.
    >> Share

  52. KARAM N, Spaulding C
    Interventional management of out-of-hospital cardiac arrest.
    Heart. 2023;109:719-722.
    >> Share

  53. PINTO-FILHO MM, Paixao GM, Gomes PR, Soares CPM, et al
    Electrocardiographic findings and prognostic values in patients hospitalised with COVID-19 in the World Heart Federation Global Study.
    Heart. 2023;109:668-673.
    >> Share

  54. DIEDERICHSEN SZ, Svennberg E
    Novel path: FINDing the way forward in screening for atrial fibrillation.
    Heart. 2023 Apr 5:heartjnl-2023-322395. doi: 10.1136/heartjnl-2023-322395.
    >> Share

  55. FLORIA M, Tanase DM
    Bradyarrhythmias in patients with atrial fibrillation.
    Heart. 2023 Apr 3:heartjnl-2023-322498. doi: 10.1136/heartjnl-2023-322498.
    >> Share

    March 2023
  56. MULLER SA, Te Riele ASJM
    Implantable cardioverter-defibrillator shocks during long-term follow-up in arrhythmogenic right ventricular cardiomyopathy.
    Heart. 2023 Mar 28:heartjnl-2022-322138. doi: 10.1136/heartjnl-2022-322138.
    >> Share

  57. MARON MS, Rowin E, Spirito P, Maron BJ, et al
    Differing strategies for sudden death prevention in hypertrophic cardiomyopathy.
    Heart. 2023;109:589-594.
    >> Share

  58. AHN HJ, Lee SR, Choi EK, Lee SW, et al
    Metabolic syndrome and ischaemic stroke in non-anticoagulated atrial fibrillation with low CHA(2)DS(2)-VASc scores.
    Heart. 2023 Mar 24:heartjnl-2022-322143. doi: 10.1136/heartjnl-2022-322143.
    >> Share

  59. FRAUSING MHJP, Van De Lande ME, Maass AH, Nguyen BO, et al
    Brady- and tachyarrhythmias detected by continuous rhythm monitoring in paroxysmal atrial fibrillation.
    Heart. 2023 Mar 22:heartjnl-2022-322253. doi: 10.1136/heartjnl-2022-322253.
    >> Share

  60. MOLITOR N, Hofer D, Cimen T, Gasperetti A, et al
    Evolution and triggers of defibrillator shocks in patients with arrhythmogenic right ventricular cardiomyopathy.
    Heart. 2023 Mar 16:heartjnl-2022-321739. doi: 10.1136/heartjnl-2022-321739.
    >> Share

  61. FINK T, Sciacca V, Sommer P
    Catheter ablation of atrial fibrillation after percutaneous left atrial appendage closure: friend or foe?
    Heart. 2023 Mar 1:heartjnl-2023-322374. doi: 10.1136/heartjnl-2023-322374.
    >> Share

    February 2023
  62. SPECTERMAN MJ, Behr ER
    Cardiogenetics: the role of genetic testing for inherited arrhythmia syndromes and sudden death.
    Heart. 2023;109:434-441.
    >> Share

  63. BORSCHEL CS, Ortega-Alonso A, Havulinna AS, Jousilahti P, et al
    Inflammatory proteomics profiling for prediction of incident atrial fibrillation.
    Heart. 2023 Feb 17:heartjnl-2022-321959. doi: 10.1136/heartjnl-2022-321959.
    >> Share

  64. NADARAJAH R, Wu J, Hogg D, Raveendra K, et al
    Prediction of short-term atrial fibrillation risk using primary care electronic health records.
    Heart. 2023 Feb 9:heartjnl-2022-322076. doi: 10.1136/heartjnl-2022-322076.
    >> Share

  65. CHEN JJ, Chiu FC, Chang SN, Cheng HL, et al
    Impact of pre-existing left atrial appendage occluder on catheter ablation of atrial fibrillation.
    Heart. 2023 Feb 7:heartjnl-2022-321934. doi: 10.1136/heartjnl-2022-321934.
    >> Share

  66. KIM J, Kim D, Jang E, Kim D, et al
    Associations of high-normal blood pressure and impaired fasting glucose with atrial fibrillation.
    Heart. 2023 Feb 7:heartjnl-2022-322094. doi: 10.1136/heartjnl-2022-322094.
    >> Share

    January 2023
  67. OTTO CM
    Heartbeat: prevention of atrial fibrillation progression.
    Heart. 2023;109:159-161.
    >> Share

  68. JOY M, Williams J, Emanuel S, Kar D, et al
    Trends in direct oral anticoagulant (DOAC) prescribing in English primary care (2014-2019).
    Heart. 2023;109:195-201.
    >> Share

  69. LINZ D, Schnabel RB
    Gut microbiota-derived metabolites in atrial fibrillation: risk markers or modifiable risk factors?
    Heart. 2023 Jan 2:heartjnl-2022-321806. doi: 10.1136/heartjnl-2022-321806.
    >> Share

  70. ABDULSALAM NM, Poole JE
    When will we learn? Differential outcomes in women following catheter ablation of atrial fibrillation.
    Heart. 2023 Jan 2:heartjnl-2022-322092. doi: 10.1136/heartjnl-2022-322092.
    >> Share

  71. LUCIANI M, Muller D, Vanetta C, Diteepeng T, et al
    Trimethylamine-N-oxide is associated with cardiovascular mortality and vascular brain lesions in patients with atrial fibrillation.
    Heart. 2023 Jan 2:heartjnl-2022-321300. doi: 10.1136/heartjnl-2022-321300.
    >> Share

    December 2022
  72. ANDERSON RH, Garbi M, Zugwitz D, Petersen SE, et al
    Anatomy of the mitral valve relative to controversies concerning the so-called annular disjunction.
    Heart. 2022 Dec 30:heartjnl-2022-322043. doi: 10.1136/heartjnl-2022-322043.
    >> Share

  73. PELLEGRINI CN, Buzkova P, Oesterle A, Heckbert SR, et al
    Dysregulated carbohydrate and lipid metabolism and risk of atrial fibrillation in advanced old age.
    Heart. 2022 Dec 22:heartjnl-2022-321633. doi: 10.1136/heartjnl-2022-321633.
    >> Share

  74. ARPS K, Piccini JP
    Women, men and the safety gap after catheter ablation of atrial fibrillation.
    Heart. 2022 Dec 22:heartjnl-2022-321632. doi: 10.1136/heartjnl-2022-321632.
    >> Share

  75. LOPEZ-LIZARRAGA MA, Ezquerra-Osorio A, Cueva-Parra A
    Woman with alternating QRS in the emergency department: what is happening?
    Heart. 2022;109:95-158.
    >> Share

  76. BULARGA A, Newby DE, Chapman AR
    Not to be sneezed at: cardiovascular disease after COVID-19 infection.
    Heart. 2022;109:84-85.
    >> Share

  77. SCARSINI R, Pighi M, Mainardi A, Portolan L, et al
    Proof of concept study on coronary microvascular function in low flow low gradient aortic stenosis.
    Heart. 2022 Dec 13:heartjnl-2022-321907. doi: 10.1136/heartjnl-2022-321907.
    >> Share

    November 2022
  78. WILKINSON C, Rockwood K
    Frailty assessment in the management of cardiovascular disease.
    Heart. 2022;108:1991-1995.
    >> Share

  79. GUPTA D, Ding WY, Calvert P, Williams E, et al
    Cryoballoon Pulmonary Vein Isolation as First-Line Treatment for Typical Atrial Flutter.
    Heart. 2022 Nov 17. pii: heartjnl-2022-321729. doi: 10.1136/heartjnl-2022-321729
    >> Share

  80. WEBER C, Hung J, Hickling S, Li I, et al
    Emergent readmission and long-term mortality risk after incident atrial fibrillation hospitalisation.
    Heart. 2022 Nov 16. pii: heartjnl-2022-321560. doi: 10.1136/heartjnl-2022-321560
    >> Share

  81. WALDMANN V, Khairy P
    Atrial fibrillation in Ebstein anomaly: weathering the storm.
    Heart. 2022 Nov 15. pii: heartjnl-2022-321876. doi: 10.1136/heartjnl-2022-321876
    >> Share

  82. MARTIN DE MIGUEL I, Madhavan M, Miranda WR, Connolly HM, et al
    Prognostic implications of atrial fibrillation in adults with Ebstein anomaly.
    Heart. 2022 Nov 11. pii: heartjnl-2022-321493. doi: 10.1136/heartjnl-2022-321493
    >> Share

  83. BURSI F, Lee AP
    Strain and mitral regurgitation: is atrial functional mitral regurgitation a ventricular disease?
    Heart. 2022 Nov 11. pii: heartjnl-2022-321945. doi: 10.1136/heartjnl-2022-321945
    >> Share

  84. KITAI T, Nabeta T, Naruse Y, Taniguchi T, et al
    Comparisons between biopsy-proven versus clinically diagnosed cardiac sarcoidosis.
    Heart. 2022;108:1887-1894.
    >> Share

  85. AEBERSOLD H, Serra-Burriel M, Foster-Wittassek F, Moschovitis G, et al
    Patient clusters and cost trajectories in the Swiss Atrial Fibrillation cohort.
    Heart. 2022 Nov 4. pii: heartjnl-2022-321520. doi: 10.1136/heartjnl-2022-321520.
    >> Share

    October 2022
  86. CASO V, de Groot JR, Sanmartin Fernandez M, Segura T, et al
    Outcomes and drivers of inappropriate dosing of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a systematic review and meta-analysis.
    Heart. 2022 Oct 31. pii: heartjnl-2022-321114. doi: 10.1136/heartjnl-2022-321114
    >> Share

  87. LANE DJ, Grunau B, Kudenchuk P, Dorian P, et al
    Bayesian analysis of amiodarone or lidocaine versus placebo for out-of-hospital cardiac arrest.
    Heart. 2022;108:1777-1783.
    >> Share

  88. MEUCCI MC, Stassen J, Tomsic A, Palmen M, et al
    Prognostic impact of left ventricular global longitudinal strain in atrial mitral regurgitation.
    Heart. 2022 Oct 21. pii: heartjnl-2022-321698. doi: 10.1136/heartjnl-2022-321698
    >> Share

  89. LYNGBAKKEN MN, Ronningen PS, Solberg MG, Berge T, et al
    Prediction of incident atrial fibrillation with cardiac biomarkers and left atrial volumes.
    Heart. 2022 Oct 19. pii: heartjnl-2022-321608. doi: 10.1136/heartjnl-2022-321608
    >> Share

  90. RAMLAKHAN KP, Kauling RM, Schenkelaars N, Segers D, et al
    Supraventricular arrhythmia in pregnancy.
    Heart. 2022;108:1674-1681.
    >> Share

    September 2022
  91. HENDRIKS JM, Elliott AD, Middeldorp ME, Sanders P, et al
    Contributing factors to personalised medicine in atrial fibrillation.
    Heart. 2022 Sep 29. pii: heartjnl-2022-321553. doi: 10.1136/heartjnl-2022-321553
    >> Share

  92. LAWIN D, Lawrenz T, Marx K, Danielsmeier NB, et al
    Gender disparities in alcohol septal ablation for hypertrophic obstructive cardiomyopathy.
    Heart. 2022;108:1623-1628.
    >> Share

  93. MSZAR R, Friedman DJ, Ong E, Du C, et al
    Sex-based differences in atrial fibrillation ablation adverse events.
    Heart. 2022 Sep 14. pii: heartjnl-2022-321192. doi: 10.1136/heartjnl-2022-321192
    >> Share

  94. MARSCHNER S, von Huben A, Zaman S, Reynolds HR, et al
    Pregnancy-related cardiovascular conditions and outcomes in a United States Medicaid population.
    Heart. 2022;108:1524-1529.
    >> Share

    August 2022
  95. VAN DER VELDEN RMJ, Pluymaekers NAHA, Dudink EAMP, Luermans JGLM, et al
    Mobile health adherence for the detection of recurrent recent-onset atrial fibrillation.
    Heart. 2022 Aug 29. pii: heartjnl-2022-321346. doi: 10.1136/heartjnl-2022-321346
    >> Share

  96. SANCHEZ-QUINTANA D, Anderson RH, Tretter JT, Cabrera JA, et al
    Anatomy of the conduction tissues 100 years on: what have we learned?
    Heart. 2022;108:1430-1437.
    >> Share

    July 2022
  97. PARALE C, Velayutham R, Anantharaj A
    Tachycardia in a young man: does pulse oximetry give a clue?
    Heart. 2022;108:1266-1330.
    >> Share

  98. NGUYEN BO, Weberndorfer V, Crijns HJ, Geelhoed B, et al
    Prevalence and determinants of atrial fibrillation progression in paroxysmal atrial fibrillation.
    Heart. 2022 Jul 20. pii: heartjnl-2022-321027. doi: 10.1136/heartjnl-2022-321027
    >> Share

  99. VILALTA V, Cediel G, Mohammadi S, Lopez H, et al
    New-onset persistent left bundle branch block following sutureless aortic valve replacement.
    Heart. 2022 Jul 16. pii: heartjnl-2022-321191. doi: 10.1136/heartjnl-2022-321191
    >> Share

  100. KANY S, Cardoso VR, Bravo L, Williams JA, et al
    Eligibility for early rhythm control in patients with atrial fibrillation in the UK Biobank.
    Heart. 2022 Jul 14. pii: heartjnl-2022-321196. doi: 10.1136/heartjnl-2022-321196
    >> Share

  101. KIM HJ, Chang DH, Kim SO, Kim JK, et al
    Left atrial appendage preservation versus closure during surgical ablation of atrial fibrillation.
    Heart. 2022 Jul 13. pii: heartjnl-2022-320939. doi: 10.1136/heartjnl-2022-320939
    >> Share

    June 2022
  102. MARROQUIN L, Tirado-Conte G, Pracon R, Streb W, et al
    Management and outcomes of patients with left atrial appendage thrombus prior to percutaneous closure.
    Heart. 2022;108:1098-1106.
    >> Share

  103. AVILA P, Calvo D, Tamargo M, Uribarri A, et al
    Association of age with clinical features and ablation outcomes of paroxysmal supraventricular tachycardias.
    Heart. 2022;108:1107-1113.
    >> Share

  104. TAN HL, Remme CA
    Sudden cardiac death: recognising hidden risk among women versus men.
    Heart. 2022;108:992-993.
    >> Share

    May 2022
  105. KUDENCHUK PJ
    Management of cardiac arrest in the cardiac catheterisation laboratory: guidelines tailored to place and occasion.
    Heart. 2022;108:907-908.
    >> Share

  106. OTTO CM
    Heartbeat: can cardiogenetics reduce adverse events due to catecholaminergic polymorphic ventricular tachycardia?
    Heart. 2022;108:816-818.
    >> Share

  107. POSTEMA PG, van der Werf C
    Catecholaminergic polymorphic ventricular tachycardia: differences in inheritance and implications for patients, families and future studies.
    Heart. 2022;108:820-821.
    >> Share

  108. SHIMAMOTO K, Ohno S, Kato K, Takayama K, et al
    Impact of cascade screening for catecholaminergic polymorphic ventricular tachycardia type 1.
    Heart. 2022;108:840-847.
    >> Share

  109. MARSMAN EMJ, Postema PG, Remme CA
    Brugada syndrome: update and future perspectives.
    Heart. 2022;108:668-675.
    >> Share

  110. HAYDOCK P, Camm AJ
    History and evolution of pacing and devices.
    Heart. 2022;108:794-799.
    >> Share

    April 2022
  111. ROSEBOOM E, Maass AH
    Inherited and modifiable factors need to be identified in young patients with atrioventricular block.
    Heart. 2022 Apr 5. pii: heartjnl-2022-320841. doi: 10.1136/heartjnl-2022-320841.
    >> Share

  112. KOMEN J, Pottegard A, Hjemdahl P, Mantel-Teeuwisse AK, et al
    Non-vitamin K antagonist oral anticoagulants, proton pump inhibitors and gastrointestinal bleeds.
    Heart. 2022;108:613-618.
    >> Share

  113. MORITA S, Malik AH, Kuno T, Ando T, et al
    Analysis of outcome of 6-month readmissions after percutaneous left atrial appendage occlusion.
    Heart. 2022;108:606-612.
    >> Share

  114. HOLT A, Blanche P, Zareini B, Rasmussen PV, et al
    Gastrointestinal bleeding risk following concomitant treatment with oral glucocorticoids in patients on non-vitamin K oral anticoagulants.
    Heart. 2022;108:626-632.
    >> Share

  115. HIGUCHI K, Bhargava M
    Management of premature ventricular complexes.
    Heart. 2022;108:565-572.
    >> Share

    March 2022
  116. PARK YJ, Park JW, Yu HT, Kim TH, et al
    Sex difference in atrial fibrillation recurrence after catheter ablation and antiarrhythmic drugs.
    Heart. 2022 Mar 24. pii: heartjnl-2021-320601. doi: 10.1136/heartjnl-2021-320601
    >> Share

  117. RAATIKAINEN P, Lassila R
    COVID-19: another reason for anticoagulation in patients with atrial fibrillation.
    Heart. 2022 Mar 21. pii: heartjnl-2022-320845. doi: 10.1136/heartjnl-2022-320845
    >> Share

  118. GILL S, Bunting KV, Sartini C, Cardoso VR, et al
    Smartphone detection of atrial fibrillation using photoplethysmography: a systematic review and meta-analysis.
    Heart. 2022 Mar 11. pii: heartjnl-2021-320417. doi: 10.1136/heartjnl-2021-320417
    >> Share

  119. HANDY A, Banerjee A, Wood AM, Dale C, et al
    Evaluation of antithrombotic use and COVID-19 outcomes in a nationwide atrial fibrillation cohort.
    Heart. 2022 Mar 10. pii: heartjnl-2021-320325. doi: 10.1136/heartjnl-2021-320325
    >> Share

  120. DYSSEKILDE JR, Christiansen MK, Johansen JB, Nielsen JC, et al
    Familial risk of atrioventricular block in first-degree relatives.
    Heart. 2022 Mar 4. pii: heartjnl-2021-320411. doi: 10.1136/heartjnl-2021-320411.
    >> Share

  121. FRANKE KB, Mahajan R
    Cardiac oxidative stress: a potential tool for risk stratification in cardiac sarcoidosis.
    Heart. 2022;108:410-411.
    >> Share

  122. YOSHITOMI R, Kobayashi S, Yano Y, Nakashima Y, et al
    Enhanced oxidative stress and presence of ventricular aneurysm for risk prediction in cardiac sarcoidosis.
    Heart. 2022;108:429-437.
    >> Share

    February 2022
  123. EVERS-DORPFELD S, Aeschbacher S, Hennings E, Eken C, et al
    Sex-specific differences in adverse outcome events among patients with atrial fibrillation.
    Heart. 2022 Feb 8. pii: heartjnl-2021-320122. doi: 10.1136/heartjnl-2021-320122.
    >> Share

  124. OTTO CM
    Heartbeat: bleeding risk in atrial fibrillation patients on non-vitamin K oral anticoagulant medications.
    Heart. 2022;108:243-245.
    >> Share

  125. GUPTA A, Arora GK, Isser HS
    An elderly woman with recurrent syncope.
    Heart. 2022;108:257-324.
    >> Share

  126. MORRONE D, De Caterina R
    Bleeding risk score: limits and practicability.
    Heart. 2022;108:246-248.
    >> Share

    January 2022
  127. TUTAREL O, Baris L, Budts W, Gamal Abd-El Aziz M, et al
    Pregnancy outcomes in women with a systemic right ventricle and transposition of the great arteries results from the ESC-EORP Registry of Pregnancy and Cardiac disease (ROPAC).
    Heart. 2022;108:117-123.
    >> Share

  128. VITALE G, Ditaranto R, Graziani F, Tanini I, et al
    Standard ECG for differential diagnosis between Anderson-Fabry disease and hypertrophic cardiomyopathy.
    Heart. 2022;108:54-60.
    >> Share

    December 2021
  129. OTTO CM
    Heartbeat: lower risk of dementia with a direct oral anticoagulatant, compared to a vitamin K antagonist, for patients with atrial fibrillation.
    Heart. 2021;107:1847-1849.
    >> Share

  130. DING WY, Mahida S
    Wide complex tachycardia: differentiating ventricular tachycardia from supraventricular tachycardia.
    Heart. 2021;107:1995-2003.
    >> Share

    November 2021
  131. OTTO CM
    Heartbeat: ECG approaches to early detection of atrial fibrillation.
    Heart. 2021;107:1765-1767.
    >> Share

    October 2021
  132. HIMELFARB JD, Shulman H, Olesovsky CJ, Rumman RK, et al
    Atrial fibrillation following transcatheter atrial septal defect closure: a systematic review and meta-analysis.
    Heart. 2021 Oct 21. pii: heartjnl-2021-319794. doi: 10.1136/heartjnl-2021-319794
    >> Share

  133. DEYELL MW, Hawkins NM
    Odd couple: premature ventricular contractions and heart failure.
    Heart. 2021 Oct 19. pii: heartjnl-2021-319986. doi: 10.1136/heartjnl-2021-319986
    >> Share

  134. CADOGAN SL, Powell E, Wing K, Wong AY, et al
    Anticoagulant prescribing for atrial fibrillation and risk of incident dementia.
    Heart. 2021 Oct 13. pii: heartjnl-2021-319672. doi: 10.1136/heartjnl-2021-319672
    >> Share

  135. CHUA W
    Clearing the cognitive cloud: direct oral anticoagulants or vitamin K antagonists for reducing dementia risk in patients with atrial fibrillation?
    Heart. 2021 Oct 13. pii: heartjnl-2021-320138. doi: 10.1136/heartjnl-2021-320138
    >> Share

  136. NADARAJAH R, Alsaeed E, Hurdus B, Aktaa S, et al
    Prediction of incident atrial fibrillation in community-based electronic health records: a systematic review with meta-analysis.
    Heart. 2021 Oct 4. pii: heartjnl-2021-320036. doi: 10.1136/heartjnl-2021-320036.
    >> Share

  137. ZAMAN J, Agarwal S
    Management of ventricular tachycardia storm.
    Heart. 2021;107:1671-1677.
    >> Share

    September 2021
  138. BARNETT-GRINESS O, Stein N, Kotler A, Saliba W, et al
    Novel bleeding prediction model in atrial fibrillation patients on new oral anticoagulants.
    Heart. 2021 Sep 21. pii: heartjnl-2021-319702. doi: 10.1136/heartjnl-2021-319702
    >> Share

  139. KASHOU A, Noseworthy P
    Predicting incident atrial fibrillation in sinus rhythm: more than just trusting the 'black box'.
    Heart. 2021 Sep 7. pii: heartjnl-2021-319385. doi: 10.1136/heartjnl-2021-319385.
    >> Share

  140. LIMPITIKUL WB, Dewland TA, Vittinghoff E, Soliman E, et al
    Premature ventricular complexes and development of heart failure in a community-based population.
    Heart. 2021 Sep 7. pii: heartjnl-2021-319473. doi: 10.1136/heartjnl-2021-319473.
    >> Share

  141. NASER JA, Pislaru S, Stan MN, Lin G, et al
    Incidence, risk factors, natural history and outcomes of heart failure in patients with Graves' disease.
    Heart. 2021 Sep 6. pii: heartjnl-2021-319752. doi: 10.1136/heartjnl-2021-319752.
    >> Share

    August 2021
  142. BLAAUW Y, Mulder B, Rienstra M
    Is catheter ablation of atrial fibrillation as first-line treatment ready for prime time?
    Heart. 2021 Aug 12. pii: heartjnl-2021-319832. doi: 10.1136/heartjnl-2021-319832
    >> Share

  143. KANY S, Schnabel R
    Adding to the evidence or to the confusion: dual antithrombotic therapy in chronic coronary syndrome and atrial fibrillation.
    Heart. 2021 Aug 12. pii: heartjnl-2021-319830. doi: 10.1136/heartjnl-2021-319830
    >> Share

  144. SCHNABEL RB, Wallenhorst C, Engler D, Blankenberg S, et al
    Refined atrial fibrillation screening and cost-effectiveness in the German population.
    Heart. 2021 Aug 10. pii: heartjnl-2020-318882. doi: 10.1136/heartjnl-2020-318882
    >> Share

  145. TOOLEY JE, Perez MV
    Role of digital health in detection and management of atrial fibrillation.
    Heart. 2021 Aug 3. pii: heartjnl-2020-318262. doi: 10.1136/heartjnl-2020-318262.
    >> Share

  146. OTTO CM
    Heartbeat: improved quality of life and reduced healthcare utilisation after catheter ablation in patients with drug-resistant paroxysmal atrial fibrillation.
    Heart. 2021;107:1271-1273.
    >> Share

    July 2021
  147. FUKAYA H, Ako J, Yasuda S, Kaikita K, et al
    Aspirin versus P2Y12 inhibitors with anticoagulation therapy for atrial fibrillation.
    Heart. 2021 Jul 14. pii: heartjnl-2021-319321. doi: 10.1136/heartjnl-2021-319321
    >> Share

  148. IMBERTI JF, Ding WY, Kotalczyk A, Zhang J, et al
    Catheter ablation as first-line treatment for paroxysmal atrial fibrillation: a systematic review and meta-analysis.
    Heart. 2021 Jul 14. pii: heartjnl-2021-319496. doi: 10.1136/heartjnl-2021-319496
    >> Share

  149. PHILLIPS K, Subramanian A, Thomas GN, Khan N, et al
    Trends in the pharmacological management of atrial fibrillation in UK general practice 2008-2018.
    Heart. 2021 Jul 5. pii: heartjnl-2021-319338. doi: 10.1136/heartjnl-2021-319338.
    >> Share

    June 2021
  150. CHEN TH, Chu YC, Ou SM, Tarng DC, et al
    Associations of atrial fibrillation with renal function decline in patients with chronic kidney disease.
    Heart. 2021 Jun 30. pii: heartjnl-2021-319297. doi: 10.1136/heartjnl-2021-319297
    >> Share

  151. MULDER BA, Rienstra M, Van Gelder IC, Blaauw Y, et al
    Update on management of atrial fibrillation in heart failure: a focus on ablation.
    Heart. 2021 Jun 4. pii: heartjnl-2020-318081. doi: 10.1136/heartjnl-2020-318081.
    >> Share

  152. SANZ-GARCIA A, Cecconi A, Vera A, Camarasaltas JM, et al
    Electrocardiographic biomarkers to predict atrial fibrillation in sinus rhythm electrocardiograms.
    Heart. 2021 Jun 4. pii: heartjnl-2021-319120. doi: 10.1136/heartjnl-2021-319120.
    >> Share

  153. MINNERS J, Jander N
    Consecutive, index and representative beats: obtaining reliable information despite an irregular heart rhythm.
    Heart. 2021;107:862-863.
    >> Share

  154. BRIGNOLE M, Rivasi G
    New insights in diagnostics and therapies in syncope: a novel approach to non-cardiac syncope.
    Heart. 2021;107:864-873.
    >> Share

  155. PARKER WA, Storey RF
    Antithrombotic therapy for patients with chronic coronary syndromes.
    Heart. 2021;107:925-933.
    >> Share

    May 2021
  156. WILDE AAM, Amin AS, Postema PG
    Diagnosis, management and therapeutic strategies for congenital long QT syndrome.
    Heart. 2021 May 26. pii: heartjnl-2020-318259. doi: 10.1136/heartjnl-2020-318259
    >> Share

  157. KAWAJI T, Ogawa H, Hamatani Y, Kato M, et al
    Association of inverted T wave during atrial fibrillation rhythm with subsequent cardiac events.
    Heart. 2021 May 26. pii: heartjnl-2021-319199. doi: 10.1136/heartjnl-2021-319199
    >> Share

  158. NICOLI CD, O'Neal WT, Levitan EB, Singleton MJ, et al
    Atrial fibrillation and risk of incident heart failure with reduced versus preserved ejection fraction.
    Heart. 2021 May 24. pii: heartjnl-2021-319122. doi: 10.1136/heartjnl-2021-319122
    >> Share

  159. ROSSIDES M, Kullberg S, Grunewald J, Eklund A, et al
    Risk and predictors of heart failure in sarcoidosis in a population-based cohort study from Sweden.
    Heart. 2021 May 21. pii: heartjnl-2021-319129. doi: 10.1136/heartjnl-2021-319129
    >> Share

  160. ELVAN A
    It's all about improvement of quality of life and reduction of disease burden in atrial fibrillation ablation.
    Heart. 2021 May 20. pii: heartjnl-2021-319382. doi: 10.1136/heartjnl-2021-319382
    >> Share

  161. BOSMAN LP, Te Riele ASJM
    Arrhythmogenic right ventricular cardiomyopathy: a focused update on diagnosis and risk stratification.
    Heart. 2021 May 14. pii: heartjnl-2021-319113. doi: 10.1136/heartjnl-2021-319113
    >> Share

  162. CHOI Y, Lee Y, Kim SH, Kim S, et al
    Single direct oral anticoagulant therapy in stable patients with atrial fibrillation beyond 1 year after coronary stent implantation.
    Heart. 2021 May 14. pii: heartjnl-2020-318750. doi: 10.1136/heartjnl-2020-318750
    >> Share

  163. GUPTA D, Ding WY
    Contemporary management of persistent atrial fibrillation.
    Heart. 2021 May 14. pii: heartjnl-2020-317422. doi: 10.1136/heartjnl-2020-317422
    >> Share

  164. CHUA W, Fabritz L
    Heart failure in patients with atrial fibrillation: why it matters now more than ever.
    Heart. 2021 May 13. pii: heartjnl-2021-319145. doi: 10.1136/heartjnl-2021-319145
    >> Share

  165. RUTHERFORD OW, Jonasson C, Ghanima W, Soderdahl F, et al
    Effectiveness and safety of oral anticoagulants in elderly patients with atrial fibrillation.
    Heart. 2021 May 11. pii: heartjnl-2020-318753. doi: 10.1136/heartjnl-2020-318753
    >> Share

  166. GUPTA D, Vijgen J, Potter T, Scherr D, et al
    Quality of life and healthcare utilisation improvements after atrial fibrillation ablation.
    Heart. 2021 May 5. pii: heartjnl-2020-318676. doi: 10.1136/heartjnl-2020-318676.
    >> Share

  167. JOLOBE O
    Next frontier is inclusion of high-grade carotid artery stenosis in the CHA2DS2 Vasc score.
    Heart. 2021;107:767.
    >> Share

  168. KARTHIKEYAN G
    Stroke risk in rheumatic heart disease.
    Heart. 2021;107:694-696.
    >> Share

  169. FAN P, Zhang Y, Lu YT, Yang KQ, et al
    Prognostic value of plasma big endothelin-1 in left ventricular non-compaction cardiomyopathy.
    Heart. 2021;107:836-841.
    >> Share

    April 2021
  170. SANTOS IS, Bensenor IM
    Cardiovascular health and atrial fibrillation.
    Heart. 2021 Apr 15. pii: heartjnl-2021-319253. doi: 10.1136/heartjnl-2021-319253
    >> Share

  171. LEE JH, Yang PS, Yu HT, Kim TH, et al
    Association of cardiovascular health and incident atrial fibrillation in elderly population.
    Heart. 2021 Apr 2. pii: heartjnl-2020-318858. doi: 10.1136/heartjnl-2020-318858.
    >> Share

  172. YEO C, Wang Y, Tan VH
    Wide complex tachycardia captured on smartwatch.
    Heart. 2021;107:626-684.
    >> Share

  173. GEURINK K, Holmes D, Ezekowitz MD, Pieper K, et al
    Patterns of oral anticoagulation use with cardioversion in clinical practice.
    Heart. 2021;107:642-649.
    >> Share

  174. SPARROW R, Sanjoy S, Choi YH, Elgendy IY, et al
    Racial, ethnic and socioeconomic disparities in patients undergoing left atrial appendage closure.
    Heart. 2021 Apr 1. pii: heartjnl-2020-318650. doi: 10.1136/heartjnl-2020-318650.
    >> Share

    February 2021
  175. SINNING CR
    Biomarkers for detection of a thrombus in the left atrial appendage: the search for the grail?
    Heart. 2021;107:176-177.
    >> Share

    January 2021
  176. SINGH T, Newby DE
    Is the fear of disease worse than the disease itself?
    Heart. 2021;107:91-92.
    >> Share

    October 2020
  177. MULDER BA, Rienstra M, Blaauw Y
    Evaluation and treatment of premature ventricular contractions in heart failure with reduced ejection fraction.
    Heart. 2020 Oct 19. pii: heartjnl-2020-317491. doi: 10.1136/heartjnl-2020-317491
    >> Share

    September 2020
  178. IHSAN J, Khand A, Adlan AM
    Ventricular storm following late presentation acute myocardial infarction.
    Heart. 2020;106:1399-1448.
    >> Share

    May 2020
  179. KIM WK, Kim HJ, Kim JB, Jung SH, et al
    Exclusion versus preservation of the left atrial appendage in rheumatic mitral valve surgery.
    Heart. 2020 May 6. pii: heartjnl-2019-316387. doi: 10.1136/heartjnl-2019-316387.
    >> Share

    January 2020
  180. TAN TC, Nunes MCP, Handschumacher M, Pontes-Neto O, et al
    Left atrial cross-sectional area is a novel measure of atrial shape associated with cardioembolic strokes.
    Heart. 2020 Jan 24. pii: heartjnl-2019-315964. doi: 10.1136/heartjnl-2019-315964
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016